| Dec'17 | Dec'16 | |||||
|---|---|---|---|---|---|---|
REVENUES (note 23) | ||||||
11,085 | 13,833 | |||||
EXPENSES | ||||||
Operating expenses (note 22, 23) | ||||||
10,616 | 10,622 | |||||
Exploration and evaluation (note 23) | ||||||
12,834 | 11,196 | |||||
General and administrative (note 23) | ||||||
5,858 | 4,420 | |||||
Impairment reversal (expense) (note 12) | ||||||
-246 | 2,320 | |||||
Foreign exchange | ||||||
611 | 1,477 | |||||
Other income (note 22) | ||||||
2,210 | 906 | |||||
Total expenses before finance charges, equity accounting and tax | ||||||
27,463 | 29,129 | |||||
Loss before finance charges, equity accounting | ||||||
-16,378 | -15,296 | |||||
Finance expense (note 22) | ||||||
858 | 811 | |||||
Equity share of income (loss) of associate (note 10) | ||||||
-489 | 453 | |||||
Loss before taxes | ||||||
-17,725 | -15,654 | |||||
Income tax recovery (expense) (note 17): Deferred | ||||||
-3,638 | -3,955 | |||||
Loss from continuing operations | ||||||
-14,087 | -11,699 | |||||
Net loss from discontinued operations (note 5) | ||||||
-81 | -5,644 | |||||
Net loss for the period | ||||||
-14,168 | -17,343 | |||||
Other comprehensive income (loss) (note 21): | ||||||
Items that may be reclassified to loss: | ||||||
Unrealized gain (loss) on investments-net of tax: Continuing operations | ||||||
4 | 3 | |||||
Unamortized experience gain post employment liability: Continuing operations | ||||||
0 | 428 | |||||
Foreign currency translation change: Continuing operations | ||||||
12,917 | 6,155 | |||||
Foreign currency translation change: Discontinued operations | ||||||
0 | 6,220 | |||||
Comprehensive loss for the period | ||||||
-1,247 | -4,537 | |||||
Basic and diluted net income (loss) per share: | ||||||
Continuing operations | ||||||
-0.03 | -0.02 | |||||
Discontinued operations | ||||||
0.00 | -0.01 | |||||
All operations | ||||||
-0.03 | -0.03 | |||||
Weighted-average number of shares outstanding (in thousands): | ||||||
Basic and diluted | ||||||
555 | 529 | |||||